Bioxyne Limited (ASX:BXN)
0.0430
+0.0010 (2.38%)
Sep 19, 2025, 10:35 AM AEST
Bioxyne Revenue
In the fiscal year ending June 30, 2025, Bioxyne had annual revenue of 30.42M AUD with 215.52% growth. Bioxyne had revenue of 17.86M in the half year ending June 30, 2025.
Revenue
30.42M
Revenue Growth
+215.52%
P/S Ratio
3.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
91.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 30.42M | 20.78M | 215.52% |
Jun 30, 2024 | 9.64M | 4.34M | 81.98% |
Jun 30, 2023 | 5.30M | 4.84M | 1,042.88% |
Jun 30, 2022 | 463.64K | -1.74M | -78.97% |
Jun 30, 2021 | 2.20M | -130.94K | -5.61% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Woolworths Group | 69.08B |
Coles Group | 44.49B |
Endeavour Group | 12.06B |
Treasury Wine Estates | 2.99B |
Metcash | 17.32B |
GrainCorp | 7.22B |
Bega Cheese | 3.54B |
IDP Education | 882.20M |
Bioxyne News
- 1 year ago - Bioxyne Delivers Australia's First Pharmaceutical Cannabis Gummies, Scales Up Manufacturing Capabilities - Benzinga